|
|
Volumn 109, Issue 1, 2000, Pages 66-67
|
|
The dilemma of disease progression in hepatitis C patients with normal serum aminotransferase levels
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
INTERFERON;
RIBAVIRIN;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
EDITORIAL;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER BIOPSY;
LIVER FIBROSIS;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VIRAL GENETICS;
ALANINE TRANSAMINASE;
BIOLOGICAL MARKERS;
BIOPSY;
CARCINOMA, HEPATOCELLULAR;
DISEASE PROGRESSION;
HEPATITIS C;
HUMANS;
LIVER;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
|
|
EID: 0034725726
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(00)00456-3 Document Type: Editorial |
|
Times cited : (8)
|
|
References (12)
|
